ICPT will launch new trial w/2,500 patients at 250 centers around the world. Estimated enrollment period (1.5yrs) plus time to interim analysis (1.5yrs) could push entry to market to year 2019-2020 if approved.
Meanwhile Gilead's NASH candidate is already in Phase 2 testing. Hugh expense plus extended time to
market equals a big down day for ICPT.
Please explain to me how repeal of the Medical Device Tax will have a negative impact on poor folks. If you can support that claim, I'll be very impressed. Please give it a try.
John McDermott (CEO) bought 25,000 shares @ $11.25 on Nov. 14, and 5,000 shares @ $11.55 on April 24.
Charles Love (Officer) bought 2,000 shares @$11.68 0n Nov. 14 and 1,000 shares @$12.14 on April 24.
Guido Neels (Officer) also purchased 10,000 shares @$11.21 on Nov. 4th
Positive? I believe so.
Insider Sales: past 3 months = 994,073 shs., past 6 months = 6,688,519 shs.
Insider Open Mkt. Buys: past 3 months = 259 shs., past 6mo. = 1,204,980 shs.
In a report issued on Sept. 30, Credit Suisse rated ELGX at 'outperform" with a target price of $17.00.
Yet their commentary supporting this rating and target price would leave you to believe that the company struggling at best. --- A very, very schizophrenic report which leaves this shareholders in doubt about the near term future of this company. -- If you have access to the report, it's worth reading. I'd be interested in the opinion of others.
dennispacko, I find it strange that you've never posted under the user name "dennispacko" before. Is it that you just happened to stumble onto this site today for the first time? What metropolitan hospital do you work for?
JMP Securities @ $700, BofA/Merrill @ $550, Wallach Beth @ $525, JP Morgan@$550.
This post has been on the board for six days now. I've been waiting to see if anyone was stupid enough to respond to this narcissist post.. -- The board members deserve a high-five.
Wedbush Securities believes that the American Association of Gynecologic Laparoscopists have taken a more positive stance towards robotic and single incision surgery. Wedbush now feels its forecast for low single digit increase in daVinci hysterectomy procedures could prove conservative. Wedbush feels that the number of hysterectomies performed with daVinci will reaccelerate in 2015, and maintains a price target on Intuitive Surgical of $514.
I think we should all be kind to jonesdexter61. He's doing the best he can with what he has to work with, which isn't very much. This is most likely his only form of recreation.
Vonpezel, Your statement... "As for the short interest,..." That is the most fallacious statement, (supported by the most convoluted logic) I've heard in a long time.